Michael D. Casey

Former Chairman, President & Chief Executive Officer at Matrix Pharmaceutical, Inc.

Michael D. Casey

Michael D. Casey

Former Chairman, President & Chief Executive Officer at Matrix Pharmaceutical, Inc.

Overview
Career Highlights

Genetic Therapy, Inc.
McNeil Pharmaceutical
Matrix Pharmaceutical, Inc.

RelSci Relationships

333

Number of Boards

11

Birthday

1946

Age

72

Relationships

Chairman & Chief Executive Officer at Celgene Corp.

Former Chief Financial Officer & Executive Vice President at Family Restaurants, Inc.

Chairman & Chief Executive Officer at Kaleido Biosciences, Inc.

Founder & Chairman at Celgene Corp.

Chief Executive Officer at ABAXIS, Inc.

Former Chief Executive Officer at Celgene Corp.

Director at Bill & Melinda Gates Foundation

Venture Partner at Pappas Capital LLC

Chairman & Chief Executive Officer at Humacyte, Inc.

Founder at Athenaeum Group

Subscribe to RelSci Professional to see 333 more Relationships
Paths to Michael D. Casey
Potential Connections via
Relationship Science
You
Michael D. Casey
Former Chairman, President & Chief Executive Officer at Matrix Pharmaceutical, Inc.
Career History
Chairman, President & Chief Executive Officer
1997 - 2002

Part of Novartis AG, Matrix Pharmaceutical, Inc. is a company headquartered in Fremont, CA, focused on in vitro and in vivo diagnostic substances. It was founded by Dennis M. Brown. On 19 Feb 02 Chiron Corp. acquired Matrix Pharmaceutical, Inc. for $58.63 million.

President, Retail & Specialty Products Divisions
1995 - 1997
President & Chief Operating Officer
1993 - 1995

Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD.

Subscribe now for extended career history
Boards & Committees
Member, Board of Directors
2010 - Current

ABAXIS, Inc. develops, manufactures and markets portable blood analysis systems. It operates through the following segments: Medical Market and Veterinary Market. The Medical Market segment serves a worldwide customer group consisting of military installations, physicians' office practices across all specialties, urgent care, outpatient and walk-in clinics health screening operations, home care providers, nursing homes, ambulance companies, oncology treatment clinics, dialysis centers, pharmacies and hospital labs. The Veterinary Market segment serves a customer group consisting of companion animal hospitals, animal clinics with mixed practices of small animals, birds and reptiles, equine and bovine practitioners, veterinary emergency clinics, veterinary referral hospitals, universities, government, pharmaceutical companies, biotechnology companies and private research laboratories. The company was founded by Vladimir E. Ostoich in April 1989 and is headquartered in Union City, CA.

Lead Independent Director
2002 - Current

Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin's lymphoma (NHL), myelofibrosis, small cell lung cancer and prostate cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies

Director
Current

Celgene Ltd. develops human pharmaceuticals and agrochemicals. It focuses on the discovery, the development, and the commercialisation of products for the treatment of cancer and other severe, immune, inflammatory conditions. The company is headquartered in Uxbridge, the United Kingdom.

Subscribe now to see 8 more corporate board memberships
Subscribe now to see non-profit board memberships for over 7 million people
Subscribe now to see government board memberships for over 7 million people
Political Donations
$250
1996

Chairman at Waxman Strategies

Subscribe now to see political donations for over 7 million people
Public Holdings
Restricted data only for RelSci Professional users.
Subscribe now to see public holdings for over 7 million people